Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma Clear Cell”

616 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 616 results

Very early researchEnded earlyNCT04906382
What this trial is testing

Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer

Who this might be right for
Lynch SyndromeRecurrent Endometrial CarcinomaRecurrent Endometrial Clear Cell Adenocarcinoma+4 more
Floor Backes, MD 2
Testing effectiveness (Phase 2)Study completedNCT02853318
What this trial is testing

Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+11 more
Roswell Park Cancer Institute 40
Early research (Phase 1)UnknownNCT05498597
What this trial is testing

AMT-151 in Patients With Selected Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorAdvanced CancerAdvanced Carcinoma+16 more
Multitude Therapeutics Inc. 30
Testing effectiveness (Phase 2)Study completedNCT01034878
What this trial is testing

Sunitinib in Metastatic Renal Cancer

Who this might be right for
Carcinoma, Renal Cell
Istituto Clinico Humanitas 25
Testing effectiveness (Phase 2)Looking for participantsNCT05127824
What this trial is testing

Autologous Dendritic Cell Vaccine in Kidney Cancer

Who this might be right for
Carcinoma, Renal Cell
Jodi Maranchie 42
Early research (Phase 1)Study completedNCT00005830
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+2 more
Gynecologic Oncology Group 31
Testing effectiveness (Phase 2)Study completedNCT00425386
What this trial is testing

Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
OHSU Knight Cancer Institute 60
Testing effectiveness (Phase 2)UnknownNCT01219751
What this trial is testing

Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Asan Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT03108066
What this trial is testing

MK-3795 (PT2385) for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma (MK-3795-003)

Who this might be right for
VHL Gene MutationVHLVHL Syndrome+8 more
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 4
Testing effectiveness (Phase 2)Study completedNCT00550277
What this trial is testing

LBH589 Treatment for Refractory Clear Cell Renal Carcinoma

Who this might be right for
Renal Cell Carcinoma
SCRI Development Innovations, LLC 20
Testing effectiveness (Phase 2)Study completedNCT00278174
What this trial is testing

Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Case Comprehensive Cancer Center 7
Not applicableWithdrawnNCT00908739
What this trial is testing

Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer

Who this might be right for
Kidney Cancer
Case Comprehensive Cancer Center
Not applicableNot Yet RecruitingNCT07168083
What this trial is testing

Efficacy and Safety of Sacituzumab in Patients With OCCC After Immunotherapy Progression

Who this might be right for
Ovarian CancerAntibody-drug ConjugatesClear Cell Adenocarcinoma of Ovary
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 22
Testing effectiveness (Phase 2)WithdrawnNCT06361810
What this trial is testing

PSMA Therapy and Immunotherapy in Kidney Cancer

Who this might be right for
Metastatic Renal Cell CarcinomaMetastatic Clear Cell Renal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Ended earlyNCT04438083
What this trial is testing

A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma (COBALT-RCC)

Who this might be right for
Renal Cell Carcinoma
CRISPR Therapeutics AG 19
Testing effectiveness (Phase 2)Study completedNCT00142415
What this trial is testing

Phase I/II Dose-escalation Study of Lutetium-177-labeled cG250 in Patients With Advanced Renal Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma
Ludwig Institute for Cancer Research 26
Not applicableStudy completedNCT00900536
What this trial is testing

DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE

Who this might be right for
Kidney Cancer
Medical Research Council
Early research (Phase 1)Study completedNCT04627064
What this trial is testing

ABEMA Alone or in COMBO With MK-6482

Who this might be right for
Clear Cell Renal Cell Carcinoma
Dana-Farber Cancer Institute 11
Not applicableStudy completedNCT01080521
What this trial is testing

Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy

Who this might be right for
Cognitive Side Effects of Cancer TherapyMalignant Ovarian Epithelial TumorOvarian Brenner Tumor+51 more
Gynecologic Oncology Group 247
Testing effectiveness (Phase 2)Study completedNCT01011933
What this trial is testing

Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+1 more
National Cancer Institute (NCI) 54
Load More Results